Kimberly-Clark (NASDAQ: KMB) closes Kenvue deal, plans $3.1 billion in integration charges

What happened

Kimberly-Clark Corporation (NASDAQ: KMB) completed its acquisition of Kenvue Inc. on Nov. 2. The deal creates one consumer health and wellness company. Its portfolio includes 10 billion-dollar brands, among them Huggies, Listerine, Tylenol and Neutrogena.

For holders, the close brings a target and a bill. Kimberly-Clark reaffirmed approximately $2.1 billion of anticipated run-rate synergies. On Oct. 30 its board approved a Kenvue Integration Program expected to cost approximately $3.1 billion in pre-tax charges through Dec. 31, 2029.

The two numbers measure different things. The synergy figure is a run-rate goal. The charges are a cost estimate over the Program's life. Both are company expectations, not results.

Key numbers

Metric	Latest	Change	Source
Cash per Kenvue share	$3.50		SEC 8-K, Item 2.01
Kimberly-Clark shares per Kenvue share	0.14625 shares		SEC 8-K, Item 2.01
Anticipated run-rate synergies	approximately $2.1 billion		SEC 8-K press release
Integration Program pre-tax charges through Dec. 31, 2029	approximately $3.1 billion		SEC 8-K, Item 2.05
Integration Program capital spending through Dec. 31, 2029	approximately $1.4 billion		SEC 8-K, Item 2.05
North America annual sales (combined, fiscal 2025, recast)	approximately $18.0 billion		SEC 8-K press release

Read more: Kimberly-Clark (KMB) company research

What Kenvue shareholders received

Each Kenvue share became the right to receive $3.50 in cash and 0.14625 shares of Kimberly-Clark common stock. Holders owed a fractional share get cash instead. In total, Kimberly-Clark delivered or must deliver approximately 281.06 million of its shares.

Kenvue stock, which traded on the New York Stock Exchange as KVUE, stopped trading at the market open on Nov. 2. Kenvue equity awards converted into equivalent Kimberly-Clark awards. The exception is performance stock units, which became time-vesting restricted stock units.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

Where the savings and costs come from

The synergy target has two parts. About $1.9 billion is cost synergies, captured in the first three years after closing. About $500 million is incremental profit from revenue synergies, captured within four years. Approximately $300 million of reinvestment partly offsets those revenue gains.

The Program began Nov. 2 and is expected to finish by Dec. 31, 2029. Of its pre-tax charges, $2.5 billion is cash. The rest is non-cash, mainly tied to supply chain network optimization.

Supply chain network optimization leads the cash charges at approximately $0.8 billion. Enterprise resource planning and technology integration follow at approximately $0.6 billion. Workforce optimization and advisory services are each approximately $0.4 billion. Program management and other restructuring and integration costs are approximately $0.3 billion.

Kimberly-Clark also expects to spend approximately $1.4 billion in capital on the Program through Dec. 31, 2029. The company says the estimates rest on assumptions and actual results may differ. It may also incur charges or cash spending it has not yet foreseen.

Why it matters

OptimistFi has argued that Kimberly-Clark's brands and supply-chain productivity drive its pricing power and cash generation. The value of that core depends on carrying out the Kenvue deal. The close settles whether the deal happens. The focus now turns to delivering savings against the costs.

The combined business will run as four segments. Management recast combined fiscal 2025 net sales to the new structure. North America is the largest at approximately $18.0 billion, followed by EMEA at approximately $5.0 billion. Asia Pacific Focus Markets and Enterprise Markets are each approximately $4.3 billion. The company calls this information illustrative and says it was not prepared under Regulation S-X pro forma rules.

The risks sit beside that scale. The company says there is no assurance the synergies and cost savings will be realized when expected or at all. It says integration costs may be higher than expected. It also cites its increased debt after the acquisition and its ability to reduce that debt and keep its credit ratings.

What's next

Kimberly-Clark has agreed to nominate Kenvue directors Richard E. Allison, Jr., Larry J. Merlo and Kirk L. Perry for election at its 2027 annual meeting of stockholders. They joined the board at the close. It now has 13 directors, after Mae C. Jemison, Christa S. Quarles and Jaime Ramirez resigned to create vacancies. The company says the resignations were not the result of any disagreement.

Executive pay is also tied to the integration. On Oct. 30 the compensation committee approved one-time premium-priced stock options, effective Dec. 1. Grant values are $6.6 million for Chairman and CEO Michael Hsu, $2.15 million for CFO Nelson Urdaneta and $1.8 million for Jeffrey Melucci. The exercise price will be the greater of $120.00 and 110% of the Dec. 1 closing price, so the options pay off only if the stock trades above that level.

They vest in full on Dec. 1, 2029, if the executive is still employed.

The case would weaken if the Program's charges climb past the company's estimate or if the three-year cost-synergy window passes without progress. It would strengthen as cost savings arrive on schedule. The company expects to file the form of the option award agreement with its annual report for the year ending Dec. 31, 2026.

More from OptimistFi

• KMB stock: research and coverage of Kimberly-Clark
• Stock research on every company OptimistFi covers

From OptimistFi Perps